Who owns BIOMARIN PHARMACEUTICAL?
- CUSIP Number: 09061gak7
Tip: Access positions for across all investors
Analyze quarterly positions in Biomarin Pharmaceutical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biomarin Pharmaceutical stock
Who bought or sold BIOMARIN PHARMACEUTICAL this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| MacKay Shields | 73M | $69M | 0% | Sep 2024 |
|
| Ing Investment Management | 70M | $66M | -17% | Sep 2024 |
|
| Wellesley Investment Advisors | 56M | $54B | -2% | Sep 2024 |
|
| Lazard Asset Management | 37M | $35M | -8% | Sep 2024 |
|
| Victory Capital Management | 17M | $16M | -1% | Sep 2024 |
|
| Thrivent Financial for Lutherans | 15M | $14M | 23% | Sep 2024 |
|
| Jpmorgan Chase & Co | 15M | $14M | 20% | Sep 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 14M | $13M | -3% | Sep 2024 |
|
| State Street Corporation | 13M | $12M | 6% | Jun 2024 |
|
| Schroder Investment Management Group | 11M | $11M | -17% | Jun 2024 |
|
| Morgan Stanley | 10M | $9.9M | 1% | Jun 2024 |
|
| Sonora Investment Management Group | 9.3M | $8.8M | -7% | Sep 2024 |
|
| Leucadia National Corporation | 9.0M | $8.7M | 68% | Jun 2024 |
|
| Franklin Resources | 8.8M | $8.4M | 76% | Sep 2024 |
|
| Bank of America Corporation | 7.2M | $6.9M | 0% | Sep 2024 |
|
| Invesco | 6.3M | $6.0M | 0% | Sep 2024 |
|
| BlackRock | 5.2M | $4.9M | 8% | Jun 2024 |
|
| Amundi | 5.0M | $4.7M | 0% | Sep 2024 |
|
| BlackRock | 4.8M | $4.5M | 100% | Sep 2024 |
|
| Bnp Paribas Investment Partners | 2.9M | $2.8M | 0% | Sep 2024 |
|
| Wells Fargo & Company | 2.7M | $2.6M | -4% | Sep 2024 |
|
| Man Group | 2.7M | $2.6M | 0% | Sep 2024 |
|
| Macquarie Group | 2.2M | $2.1M | 100% | Jun 2024 |
|
| Palisade Capital Management | 1.9M | $1.8M | 0% | Jun 2024 |
|
| Agf Management | 1.2M | $1.1M | 100% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 1.0M | $991k | -2% | Sep 2024 |
|
| Liberty Mutual Group Asset Management | 1.0M | $979k | 0% | Jun 2024 |
|
| Ofi Invest Asset Management | 1.0M | $894k | 0% | Jun 2024 |
|
| Kohlberg Kravis Roberts & Co | 967k | $927k | 38% | Jun 2024 |
|
| Mizuho Securities USA | 316k | $301k | 100% | Sep 2024 |
|
| Barclays | 549k | $523k | 100% | Sep 2024 |
|
| Sei Investments | 524k | $498k | -20% | Sep 2024 |
|
| Kornitzer Capital Management | 500k | $475k | -86% | Sep 2024 |
|
| Dnca Finance | 450k | $431k | 0% | Sep 2024 |
|
| Russell Investments | 407k | $391k | 100% | Jun 2024 |
|
| Bank of New York Mellon | 300k | $286k | 0% | Sep 2024 |
|
| American Century Companies | 288k | $275k | -9% | Sep 2024 |
|
| KBC Group NV | 250k | $238k | 0% | Sep 2024 |
|
| Zurcher Kantonalbank | 200k | $190k | 0% | Sep 2024 |
|
| Cetera Investment Advisers | 196k | $187k | 68% | Jun 2024 |
|
| Oppenheimer Asset Management | 195k | $185k | -5% | Sep 2024 |
|
| Advent Capital Management | 108k | $103k | -26% | Sep 2024 |
|
| Lake Street Advisors Group | 101k | $96k | 23% | Sep 2024 |
|
| Stephens | 99k | $94k | -7% | Sep 2024 |
|
| Mariner Wealth Advisors | 42k | $40k | 100% | Sep 2024 |
|
| Foresight Capital Management Advisors | 40k | $38k | 25% | Sep 2024 |
|
| Balboa Wealth Partners | 38k | $36k | 0% | Sep 2024 |
|
| Rollins Financial Advisors | 37k | $35k | 100% | Sep 2024 |
|
| Raab & Moskowitz Asset Management | 30k | $29k | 0% | Sep 2024 |
|
| HPM Partners | 28k | $53k | 33% | Sep 2024 |
|
| Rsm Us Wealth Management | 25k | $24k | 0% | Sep 2024 |
|
| Calamos Advisors | 16k | $15k | 0% | Sep 2024 |
|
| Brian McDonald | 15k | $14k | 0% | Sep 2024 |
|
| HB Wealth Management | 11k | $10k | 0% | Sep 2024 |
|
| Capital Investment Advisors | 11k | $10k | 0% | Sep 2024 |
|
| Raymond James Financial Services Advisors | 10k | $9.5k | 0% | Sep 2024 |
|
| Davenport & Co | 10k | $953k | 0% | Sep 2024 |
|
| EverSource Wealth Advisors | 7.0k | $6.7k | 0% | Sep 2024 |
|
| Us Bancorp | 5.0k | $4.8k | 100% | Sep 2024 |
|
| Oddo Bhf Asset Management Sas | 575.00 | $551k | 100% | Sep 2024 |
|
| Intellectus Partners | 331.00 | $316k | 25% | Sep 2024 |
|
Who sold out of Biomarin Pharmaceutical?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| iA Global Asset Management | Jun 2024 | 16M | $16M |
| Shenkman Capital Management | Jun 2024 | 11M | $10B |
| D.A. Davidson & Co. | Mar 2024 | 110k | $109k |
| Envestnet Asset Management | Jun 2024 | 10k | $9.6k |